EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease

Guendalina Bergonzoni iD, Miguel Pellegrini, Aurora Savino, Martina Lazioli, Sarah Geurs, Lorenzo Graziani iD, Denise Ferrarini iD, Solaleh Khoramian Tusi iD, Esaria Oliver iD, Jarne Geurts iD, Sara Vinciguerra iD, Michele Tebaldi iD und 11 weitere

Brain Pathology · 2026

DOI: 10.1111/bpa.70135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Guendalina Bergonzoni und 22 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of NeuroEpigenetics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy. Hauptthemen laut MEDLINE: Huntington Disease, Receptors, Dopamine D1, Medium Spiny Neurons, Receptors, Dopamine D2. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, European Regional Development Fund, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the molecular mechanisms driving selective neuronal vulnerability to different neurodegenerative disorders remains a crucial, unsolved question. Here, we explored the case of Huntington's disease (HD), where the striatum and, specifically, dopamine receptor 1 (D1R) and dopamine receptor 2 (D2R) medium‐sized spiny neurons (MSNs) exhibit differential susceptibility to the HTT CAG‐repeat expansion mutation, with D2R‐neurons being impacted earlier and more significantly. To unravel differences between D2R and D1R MSNs, we employed a multidimensional approach, integrating genomic, transcriptional, pattern distribution, and somatic instability analyses. Specifically, we used Htt CAG knock‐in mouse models harboring 18 ( Htt Q20 : “control”) or ~190 ( Htt Q175 : “HD”) consecutive CAG repeats, expressing tdTomato and EGFP under the control of Drd1 and Drd2 promoters, respectively. First, comprehensive genomic and transcriptomic analyses following fluorescence‐activated cell sorting (FACS) of dissociated striatal neurons revealed distinct gene expression profiles with a significant upregulation of oxidative phosphorylation and translation pathways in D1R‐positive neurons already at the pre‐symptomatic stage. These transcriptional changes were not accompanied by major copy number variations, as shown by parallel genomic analysis. Secondly, histological analyses revealed a greater proportion of D1R‐positive neurons compared to D2R‐positive neurons in HD mice, particularly in the ventral‐medial neostriatum, with D2R‐positive neurons presenting an increased nuclear accumulation of mutant huntingtin aggregates. In summary, our integrative study suggests that the distinct vulnerability of MSNs in HD might result from a combination of an early transcriptional compensatory response of D1R neurons together with specific susceptibility of D2R neurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseReceptors, Dopamine D1Medium Spiny NeuronsReceptors, Dopamine D2NeuronsAnimalsHuntingtin ProteinMiceMice, TransgenicDisease Models, AnimalCorpus Striatum

Stichwörter der Autor:innen

D1RD2RHuntington's diseasedifferential vulnerability, transcriptomic analysesmedium‐sized spiny neurons (MSNs)

Substanzen

Receptors, Dopamine D1Receptors, Dopamine D2Huntingtin ProteinDRD2 protein, mouse

Autor:innen und Institutionen

  • Laboratory of NeuroEpigenetics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
  • Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
  • Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Computational Genomics Laboratory, International School for Advanced Studies (SISSA), Trieste, Italy.
  • Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Guendalina Bergonzoni, Lorenzo Graziani, Denise Ferrarini, Solaleh Khoramian Tusi, Esaria Oliver, Jarne Geurts, Sara Vinciguerra, Michele Tebaldi, Takshashila Tripathi, Isabella Pesce, Alessandro Romanel, Rosario Moratalla, Jasmin Morandell, Remo Sanges, Erik Dassi, Marta Biagioli

Förderung

  • NIH HHS
  • European Regional Development Fund
  • NINDS NIH HHS
  • Italian Ministry of University and Research (MUR)
  • Marie Skłodowska Curie reintegration fellowship (the European Union's Horizon 2020 Research and Innovation Program)
  • Ministero dell'Università e della Ricerca
  • National Institutes of Health

Zitieren

APA

Bergonzoni, G., Pellegrini, M., Savino, A., Lazioli, M., Geurs, S., Graziani, L., Ferrarini, D., Tusi, S. K., Oliver, E., Geurts, J., Vinciguerra, S., Tebaldi, M., Tripathi, T., Pesce, I., Poli, V., Romanel, A., Moratalla, R., Voet, T., Morandell, J., …, & Biagioli, M. (2026). Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease. Brain Pathology. https://doi.org/10.1111/bpa.70135

Vancouver

Bergonzoni G, Pellegrini M, Savino A, Lazioli M, Geurs S, Graziani L, et al. Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease. Brain Pathology. 2026. doi:10.1111/bpa.70135

BibTeX
@article{Bergonzoni2026,
  author = {Bergonzoni, Guendalina and Pellegrini, Miguel and Savino, Aurora and Lazioli, Martina and Geurs, Sarah and Graziani, Lorenzo and Ferrarini, Denise and Tusi, Solaleh Khoramian and Oliver, Esaria and Geurts, Jarne and Vinciguerra, Sara and Tebaldi, Michele and Tripathi, Takshashila and Pesce, Isabella and Poli, Valeria and Romanel, Alessandro and Moratalla, Rosario and Voet, Thierry and Morandell, Jasmin and Sanges, Remo and Wheeler, Vanessa C and Dassi, Erik and Biagioli, Marta},
  title = {Decoding neuronal vulnerability: Multidimensional analysis of D1R ‐ and D2R ‐ medium‐sized spiny neurons in Huntington's disease},
  journal = {Brain Pathology},
  year = {2026},
  doi = {10.1111/bpa.70135}
}
Kostenlos starten →